Cargando…
Soluble Suppression of Tumorigenicity 2 and Echocardiography in Sepsis
Soluble suppression of tumorigenicity 2 (sST2) has emerged as a biomarker of cardiac stretch or remodeling, and has demonstrated a role in acutely decompensated heart failure. However, its role in sepsis-induced cardiac dysfunction is still unknown. We explored whether sST2 serum concentration refle...
Autores principales: | Yang, Hyun Suk, Hur, Mina, Kim, Hanah, Magrini, Laura, Marino, Rossella, Di Somma, Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Laboratory Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011113/ https://www.ncbi.nlm.nih.gov/pubmed/27578513 http://dx.doi.org/10.3343/alm.2016.36.6.590 |
Ejemplares similares
-
Soluble ST2 Has a Prognostic Role in Patients With Suspected Sepsis
por: Hur, Mina, et al.
Publicado: (2015) -
Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis
por: Kim, Hanah, et al.
Publicado: (2017) -
Proenkephalin, Neutrophil Gelatinase-Associated Lipocalin, and Estimated Glomerular Filtration Rates in Patients With Sepsis
por: Kim, Hanah, et al.
Publicado: (2017) -
Prognostic Role of High-sensitivity Cardiac Troponin I and Soluble Suppression of Tumorigenicity-2 in Surgical Intensive Care Unit Patients Undergoing Non-cardiac Surgery
por: Yang, Hyun Suk, et al.
Publicado: (2018) -
Diagnostic and prognostic utilities of multimarkers approach using procalcitonin, B-type natriuretic peptide, and neutrophil gelatinase-associated lipocalin in critically ill patients with suspected sepsis
por: Hur, Mina, et al.
Publicado: (2014)